Reckitt Benckiser Pharmaceuticals Inc

Type: Company
Name: Reckitt Benckiser Pharmaceuticals Inc
First reported Jul 18 2014 - Updated Jul 18 2014 - 1 reports

FDA Selects Opioid Overdose Treatment for Fast Track Development Program

A Kentucky company said that its intranasal naloxone spray, a drug designed to treat opioid overdoses, has received Fast Track designation from the Food and Drug Administration (FDA). In its release, the Company said that the Fast Track program of the ... [Published Individual.com - Jul 18 2014]
First reported Jul 16 2014 - Updated Jul 16 2014 - 1 reports

Nasally administered version of naloxone for opioid overdose emergencies receives FDA's Fast Track Designation

The first nasally administered naloxone-based therapy to treat emergency cases of opioid overdose from heroin or prescription painkillers received a Fast Track Designation from the FDA, product developer AntiOp said in a July 15 statement."This Fast Track ... [Published Fierce Drug Delivery - Jul 16 2014]
First reported Jul 10 2014 - Updated Jul 10 2014 - 1 reports

OVERNIGHT HEALTHCARE: Senate Dems unveil bill to reverse Hobby Lobby ruling

Senate Democrats introduced legislation on Wednesday to effectively reverse the Supreme Court’s decision exempting some employers from providing insurance coverage for contraception.The bill would bar for-profit, closely held corporations from seeking ... [Published The Hill - Jul 10 2014]
First reported Jul 09 2014 - Updated Jul 09 2014 - 1 reports

Adelson makes fifth new hire to fight online gaming - IFA notches win in Chicago wage fight

With Tarini Parti and Adam SneedADELSON MAKES FIFTH NEW HIRE TO FIGHT ONLINE GAMING: The casino company run by Republican megadonor Sheldon Adelson has hired former Republican congressman Connie Mack and his firm Mack Strategies . Mack will be working ... [Published Politico - Jul 09 2014]
First reported Jun 30 2014 - Updated Jun 30 2014 - 1 reports

XenoPort Announces Initiation of a Phase 2 Clinical Trial of XP23829 in Patients With Psoriasis

XenoPort, Inc. announced today that it has initiated a Phase 2 clinical trial of XP23829, its proprietary investigational next-generation fumaric acid product candidate. The trial is a multi-center, randomized, double-blind, placebo-controlled study designed ... [Published Drugs.com - Jun 30 2014]
First reported Jun 23 2014 - Updated Jun 23 2014 - 1 reports

XenoPort Announces Initiation of a Phase 2 Clinical Trial of XP23829 in Patients With Psoriasis

XenoPort, Inc. (Nasdaq: XNPT) announced today that it has initiated aPhase 2 clinical trial of XP23829, its proprietary investigationalnext-generation fumaric acid product candidate. The trial is amulti-center, randomized, double-blind, placebo-controlled ... [Published BioPortfolio - Jun 23 2014]
First reported May 21 2014 - Updated May 21 2014 - 1 reports

AntiOp Partners with Reckitt Benckiser Pharmaceuticals, Inc. to Develop Nasally Administered Treatment for Opioid Overdose

LEXINGTON, Ky.--(BUSINESS WIRE)--AntiOp, Inc. has signed an agreement with Reckitt Benckiser Pharmaceuticals, Inc. to accelerate production and worldwide marketing of intranasal naloxone, a drug designed to treat opioid overdose. ... [Published Business Wire Health News - May 21 2014]

Quotes

"The FDA has been very supportive of how we are developing our technology," said AntiOp founder and CEO Daniel Wermeling. "This Fast Track designation, combined with our recent collaboration with Reckitt Benckiser Pharmaceuticals Inc., validates our vision and belief that this drug has the potential to fulfill an unmet medical need in the U S " The latest data from the CDC, for 2011 data, demonstrated that the national opioid overdose death rate continues to climb...
...The novelty lies in the nasally administered formulation. "Nasal delivery requires a much higher concentration of the active ingredient that is stable because the nasal cavity can't hold a large volume" he said during the interview
CareFirst BlueCross BlueShield will hold a discussion on "The Promise of Care Coordination and Future of PCMH [patient-centered medical home]: Driving Quality Gains and Cost Savings."
...very pleased that Liz is joining us," said John Brownlee, practice group leader for the firm's Government Contracts and Enforcement Defense Group. "Her addition continues the expansion of our government contracts group, which has already seen growth this year with two new partners joining us. We see these moves as an opportunity to build the practice nationally."

More Content

All (10) | News (7) | Reports (0) | Blogs (1) | Audio/Video (0) | Fact Sheets (0) | Press Releases (2)
sort by: Date | Relevance
FDA Selects Opioid Overdose Treatment for Fast ... [Published Individual.com - Jul 18 2014]
Nasally administered version of naloxone for op... [Published Fierce Drug Delivery - Jul 16 2014]
OVERNIGHT HEALTHCARE: Senate Dems unveil bill t... [Published The Hill - Jul 10 2014]
Adelson makes fifth new hire to fight online ga... [Published Politico - Jul 09 2014]
XenoPort Announces Initiation of a Phase 2 Clin... [Published Drugs.com - Jun 30 2014]
XenoPort Announces Initiation of a Phase 2 Clin... [Published BioPortfolio - Jun 23 2014]
AntiOp Partners with Reckitt Benckiser Pharmace... [Published Business Wire Health News - May 21 2014]
Reckitt Benckiser Pharmaceuticals Inc. Enters I... [Published Financial Services - May 19 2014]
Reckitt Benckiser Pharmaceuticals and XenoPort ... [Published Financial Services - May 15 2014]
The Holistic Sanctuary Rebuts Boston University... [Published PRWeb - Nov 27 2013]
1
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
AntiOp Partners with Reckitt Benckiser Pharmace... [Published Business Wire Health News - May 21 2014]
LEXINGTON, Ky.--(BUSINESS WIRE)--AntiOp, Inc. has signed an agreement with Reckitt Benckiser Pharmaceuticals, Inc. to accelerate production and worldwide marketing of intranasal naloxone, a drug designed to treat opioid overdose. ...
1

Press Releases

sort by: Date | Relevance
Reckitt Benckiser Pharmaceuticals Inc. Enters I... [Published Financial Services - May 19 2014]
Reckitt Benckiser Pharmaceuticals and XenoPort ... [Published Financial Services - May 15 2014]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.